Chemoinformaics analysis of Cannabigerovarinic-Acid
| Molecular Weight | 332.44 | nRot | 8 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 9 |
| Exact Molecular Weight | 332.199 | nRing | 1 |
| Solubility: LogS | -3.197 | nHRing | 0 |
| Solubility: LogP | 6.713 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 55.2782 |
| nHD | 3 | BPOL | 28.9578 |
| QED | 0.586 |
| Synth | 2.835 |
| Natural Product Likeliness | 2.191 |
| NR-PPAR-gamma | 0.929 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.108 |
| Pgp-sub | 0.007 |
| HIA | 0.013 |
| CACO-2 | -5.01 |
| MDCK | 0.00000898 |
| BBB | 0.039 |
| PPB | 0.978111 |
| VDSS | 1.932 |
| FU | 0.0327706 |
| CYP1A2-inh | 0.24 |
| CYP1A2-sub | 0.188 |
| CYP2c19-inh | 0.055 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.67 |
| CYP2c9-sub | 0.416 |
| CYP2d6-inh | 0.831 |
| CYP2d6-sub | 0.136 |
| CYP3a4-inh | 0.047 |
| CYP3a4-sub | 0.035 |
| CL | 3.933 |
| T12 | 0.658 |
| hERG | 0.029 |
| Ames | 0.004 |
| ROA | 0.369 |
| SkinSen | 0.23 |
| Carcinogencity | 0.144 |
| EI | 0.051 |
| Respiratory | 0.726 |
| NR-Aromatase | 0.018 |
| Antiviral | Yes |
| Prediction | 0.593843 |